Pfizer Inc. Stock
€26.04
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Pfizer
sharewise wants to provide you with the best news and tools for Pfizer, so we directly link to the best financial data sources.
Financials
News
Is Pfizer a Buy Right Now or a Value Trap?
Pfizer (NYSE: PFE) has been around for 175 years, selling a wide range of drugs in various treatment areas over time. But this pharma giant truly became a household name a few years ago. Pfizer made
3 Surprisingly Underrated Stocks to Buy Right Now
Nearly everyone likes an underdog. They're the ones who don't get the respect they deserve but often deliver pleasant surprises.
Three Motley Fool contributors think they've identified a handful of
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Companies with high dividend yields can seem attractive, but there is far more to income stocks than above-average yields. Any corporation's payouts are in danger without a robust business backing
2 Beaten-Down Stocks to Buy and Hold for a Decade
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were rockstars on the stock market a few years ago. Both companies developed successful coronavirus vaccines, efforts for which they were being
3 Dirt Cheap Stocks to Buy Right Now
By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found.
Three Motley Fool contributors think they've identified dirt-cheap
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
It was a rock star during the coronavirus pandemic, but Pfizer (NYSE: PFE) hasn't been the most exciting company in 2024. Its stock has become something of a value play, at least according to one
Got $5,000? 3 Dirt Cheap Stocks to Buy Right Now
Investing $5,000 in the stock market can be a significant amount of money if you keep it invested for the very long haul. Suppose you find a good growth stock that rises by an average of 15% over a
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
Though the S&P 500 dipped earlier this month, it's important to keep in mind that we're still in a very positive market environment. The bull market is going strong, with the benchmark rising 17% so
2 Beaten-Down Stocks That Could Be Great Buys on the Dip
The stock market has been on fire this year, but much of that performance can be attributed to a handful of tech giants that have a disproportionate weight of the S&P 500 and are benefiting from the
3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
There are a million and one ways to make a buck on Wall Street, but some methods are more reliable than others. If you're an investor looking for a way to beef up your passive income stream or you
A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
I've kicked myself for not buying a stock sooner more times than I'd like to admit. Even worse are the stocks I should have bought but never did. If you invest long enough, you'll no doubt feel the
Why Walgreens Boots Alliance Plunged Today
Shares of beleaguered drug store and pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) fell 8.4% on Tuesday as of 3:22 p.m. ET.
The reason for the drop today appears to be twofold: One, Pfizer
Is Pfizer Stock Still a Buy After an Unexpected Setback?
With Pfizer (NYSE: PFE) stock badly underperforming the market over the past three years, falling by 32% while the market rose by close to the same amount, the last thing shareholders want to hear
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks
Dividend stocks can be a great source of cash flow for your portfolio. You don't need to settle for stocks that pay just a few percentage points, either. Some fairly safe, high-yielding stocks pay
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) recently fell behind in their race with Moderna (NASDAQ: MRNA) to develop new combination shots that could be worth billions in annual sales. Top-line
Is Pfizer Stock Ready to Bounce Back?
Pharmaceutical giant Pfizer (NYSE: PFE) has been in a bit of a freefall since early 2022, with shares down by 46%. Pfizer's revenue and earnings dropped off a cliff along with its
Why Pfizer Stock Slumped on Friday
In the thick of the coronavirus pandemic several years ago, any positive news from a developer of COVID-19 vaccines or drugs would have been met with a surge of buying in its stock. We're not in
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
The market is a bit jittery right now thanks to a confluence of factors, including a weaker-than-anticipated U.S. jobs report, international geopolitical issues, and foreign currency disruptions --
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With $100 Now
Would you like to improve your passive income stream but don't have a lot of extra cash to throw around? If so, I have great news: These days, $100 is all it takes to acquire a share of three top
Is Pfizer Stock a Buy Now After Earnings?
While the COVID-19 pandemic is an increasingly distant memory for most investors, Pfizer (NYSE: PFE) has struggled to move past the overhang of record vaccine sales and earnings in 2021 and 2022
Should Pfizer's Strong Quarter Calm Investor Concerns About the Stock?
Demand for COVID-19 vaccines and drugs has been fading for a while now. And that has put a big dent in Pfizer's (NYSE: PFE) sales and profit numbers. On top of that, the stock is also facing
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
The past week has been a rotten one for most portfolios. On Monday, Aug. 5, the benchmark S&P 500 index began the trading session about 3% lower. That led the benchmark index to a loss of about 9.4%
Is This Decision by Pfizer Bad News for Eli Lilly?
Eli Lilly (NYSE: LLY) stock has soared by double digits over the past year -- and for good reason. The pharma giant sells two of the most sought-after drugs today, weight loss treatments Mounjaro
Is Pfizer Winning Its $43 Billion Bet?
Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the